What Is the Risk of Dislocation and Revision in Proximal Femoral Replacement with Dual-mobility Articulation After Two-stage Revision for Periprosthetic Hip Infection?


Journal

Clinical orthopaedics and related research
ISSN: 1528-1132
Titre abrégé: Clin Orthop Relat Res
Pays: United States
ID NLM: 0075674

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 18 10 2022
accepted: 13 02 2023
pmc-release: 01 09 2024
medline: 23 8 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

Dislocation is a major complication of revision THA after two-stage exchange for periprosthetic joint infection (PJI). The likelihood of dislocation can be particularly high if megaprosthetic proximal femoral replacement (PFR) has been performed during a second-stage reimplantation. Dual-mobility acetabular components are an established way of reducing the instability risk in revision THA; however, the likelihood of dislocation for dual-mobility reconstructions in the setting of a two-stage PFR has not been studied systematically, although patients with these reconstructions might be at an increased risk. (1) What is the risk of dislocation and revision for dislocation in patients who underwent PFR with a dual-mobility acetabular component as part of two-stage exchange for hip PJI? (2) What is the risk of all-cause implant revision and what other procedures were performed (apart from revision for a dislocation) in these patients? (3) What potential patient-related and procedure-related factors are associated with dislocation? This was a retrospective study from a single academic center including procedures performed between 2010 and 2017. During the study period, 220 patients underwent two-stage revision for chronic hip PJI. Two-stage revision was the approach of choice for chronic infections, and we did not perform single-stage revisions for this indication during the study period. Thirty-three percent (73 of 220) of patients underwent second-stage reconstruction with a single-design, modular, megaprosthetic PFR because of femoral bone loss, using a cemented stem. A cemented dual-mobility cup was the approach of choice for acetabular reconstruction in the presence of a PFR; however, 4% (three of 73) were reconstructed with a bipolar hemiarthroplasty to salvage an infected saddle prosthesis, leaving 70 patients with a dual-mobility acetabular component and a PFR (84% [59 of 70]) or total femoral replacement (16% [11 of 70]). We used two similar designs of an unconstrained cemented dual-mobility cup during the study period. The median (interquartile range) patient age was 73 years (63 to 79 years), and 60% (42 of 70) of patients were women. The mean follow-up period was 50 ± 25 months with a minimum follow-up of 24 months for patients who did not undergo revision surgery or died (during the study period, 10% [seven of 70] died before 2 years). We recorded patient-related and surgery-related details from the electronic patient records and investigated all revision procedures performed until December 2021. Patients who underwent closed reduction for dislocation were included. Radiographic measurements of cup positioning were performed using supine AP radiographs obtained within the first 2 weeks after surgery using an established digital method. We calculated the risk for revision and dislocation using a competing-risk analysis with death as a competing event, providing 95% confidence intervals. Differences in dislocation and revision risks were assessed with Fine and Gray models providing subhazard ratios. All p values were two sided and the p value for significance was set at 0.05. The risk of dislocation (using a competing-risks survivorship estimator) was 17% (95% CI 9% to 32%) at 5 years, and the risk of revision for dislocation was 12% (95% CI 5% to 24%) at 5 years among patients treated with dual-mobility acetabular components as part of a two-stage revision for PJI of the hip. The risk of all-cause implant revision (using a competing-risk estimator, except for dislocation) was 20% (95% CI 12% to 33%) after 5 years. Twenty-three percent (16 of 70) of patients underwent revision surgery for reinfection and 3% (two of 70) of patients underwent stem exchange for a traumatic periprosthetic fracture. No patients underwent revision for aseptic loosening. We found no differences in patient-related and procedure-related factors or acetabular component positioning for patients with dislocation with the numbers available; however, patients with total femoral replacements had a higher likelihood of dislocation (subhazard ratio 3.9 [95% CI 1.1 to 13.3]; p = 0.03) and revision for a dislocation (subhazard ratio 4.4 [95% CI 1 to 18.5]; p = 0.04) than those who received PFR. Although dual-mobility bearings might be an intuitive potential choice to reduce the dislocation risk in revision THA, there is a considerable dislocation risk for PFR after two-stage surgery for PJI, particularly in patients with total femoral replacements. Although the use of an additional constraint might appear tempting, published results vary tremendously, and future studies should compare the performance of tripolar constrained implants to that of unconstrained dual-mobility cups in patients with PFR to reduce the risk of instability. Level III, therapeutic study.

Sections du résumé

BACKGROUND
Dislocation is a major complication of revision THA after two-stage exchange for periprosthetic joint infection (PJI). The likelihood of dislocation can be particularly high if megaprosthetic proximal femoral replacement (PFR) has been performed during a second-stage reimplantation. Dual-mobility acetabular components are an established way of reducing the instability risk in revision THA; however, the likelihood of dislocation for dual-mobility reconstructions in the setting of a two-stage PFR has not been studied systematically, although patients with these reconstructions might be at an increased risk.
QUESTIONS/PURPOSES
(1) What is the risk of dislocation and revision for dislocation in patients who underwent PFR with a dual-mobility acetabular component as part of two-stage exchange for hip PJI? (2) What is the risk of all-cause implant revision and what other procedures were performed (apart from revision for a dislocation) in these patients? (3) What potential patient-related and procedure-related factors are associated with dislocation?
METHODS
This was a retrospective study from a single academic center including procedures performed between 2010 and 2017. During the study period, 220 patients underwent two-stage revision for chronic hip PJI. Two-stage revision was the approach of choice for chronic infections, and we did not perform single-stage revisions for this indication during the study period. Thirty-three percent (73 of 220) of patients underwent second-stage reconstruction with a single-design, modular, megaprosthetic PFR because of femoral bone loss, using a cemented stem. A cemented dual-mobility cup was the approach of choice for acetabular reconstruction in the presence of a PFR; however, 4% (three of 73) were reconstructed with a bipolar hemiarthroplasty to salvage an infected saddle prosthesis, leaving 70 patients with a dual-mobility acetabular component and a PFR (84% [59 of 70]) or total femoral replacement (16% [11 of 70]). We used two similar designs of an unconstrained cemented dual-mobility cup during the study period. The median (interquartile range) patient age was 73 years (63 to 79 years), and 60% (42 of 70) of patients were women. The mean follow-up period was 50 ± 25 months with a minimum follow-up of 24 months for patients who did not undergo revision surgery or died (during the study period, 10% [seven of 70] died before 2 years). We recorded patient-related and surgery-related details from the electronic patient records and investigated all revision procedures performed until December 2021. Patients who underwent closed reduction for dislocation were included. Radiographic measurements of cup positioning were performed using supine AP radiographs obtained within the first 2 weeks after surgery using an established digital method. We calculated the risk for revision and dislocation using a competing-risk analysis with death as a competing event, providing 95% confidence intervals. Differences in dislocation and revision risks were assessed with Fine and Gray models providing subhazard ratios. All p values were two sided and the p value for significance was set at 0.05.
RESULTS
The risk of dislocation (using a competing-risks survivorship estimator) was 17% (95% CI 9% to 32%) at 5 years, and the risk of revision for dislocation was 12% (95% CI 5% to 24%) at 5 years among patients treated with dual-mobility acetabular components as part of a two-stage revision for PJI of the hip. The risk of all-cause implant revision (using a competing-risk estimator, except for dislocation) was 20% (95% CI 12% to 33%) after 5 years. Twenty-three percent (16 of 70) of patients underwent revision surgery for reinfection and 3% (two of 70) of patients underwent stem exchange for a traumatic periprosthetic fracture. No patients underwent revision for aseptic loosening. We found no differences in patient-related and procedure-related factors or acetabular component positioning for patients with dislocation with the numbers available; however, patients with total femoral replacements had a higher likelihood of dislocation (subhazard ratio 3.9 [95% CI 1.1 to 13.3]; p = 0.03) and revision for a dislocation (subhazard ratio 4.4 [95% CI 1 to 18.5]; p = 0.04) than those who received PFR.
CONCLUSION
Although dual-mobility bearings might be an intuitive potential choice to reduce the dislocation risk in revision THA, there is a considerable dislocation risk for PFR after two-stage surgery for PJI, particularly in patients with total femoral replacements. Although the use of an additional constraint might appear tempting, published results vary tremendously, and future studies should compare the performance of tripolar constrained implants to that of unconstrained dual-mobility cups in patients with PFR to reduce the risk of instability.
LEVEL OF EVIDENCE
Level III, therapeutic study.

Identifiants

pubmed: 36897193
doi: 10.1097/CORR.0000000000002623
pii: 00003086-990000000-01120
pmc: PMC10427046
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1792-1799

Informations de copyright

Copyright © 2023 by the Association of Bone and Joint Surgeons.

Déclaration de conflit d'intérêts

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

Références

Abdel MP. CORR insights(R): what is the dislocation and revision rate of dual-mobility cups used in complex revision THAs? Clin Orthop Relat Res. 2021;479:286-287.
Abdelaziz H, Schroder M, Shum Tien C, et al. Resection of the proximal femur during one-stage revision for infected hip arthroplasty: risk factors and effectiveness. Bone Joint J. 2021;103:1678-1685.
Alvand A, Grammatopoulos G, de Vos F, et al. Clinical outcome of massive endoprostheses used for managing periprosthetic joint infections of the hip and knee. J Arthroplasty. 2018;33:829-834.
Corona PS, Vicente M, Lalanza M, Amat C, Carrera L. Use of modular megaprosthesis in managing chronic end-stage periprosthetic hip and knee infections: is there an increase in relapse rate? Eur J Orthop Surg Traumatol. 2018;28:627-636.
Derksen A, Kluge M, Wirries N, et al. Constrained tripolar liner in patients with high risk of dislocation - analysis of incidence and risk of failure. J Orthop. 2021;25:288-294.
Diaz-Ledezma C, Higuera CA, Parvizi J. Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013;471:2374-2382.
Dieckmann R, Schmidt-Braekling T, Gosheger G, Theil C, Hardes J, Moellenbeck B. Two stage revision with a proximal femur replacement. BMC Musculoskelet Disord. 2019;20:58.
Grammatopoulos G, Alvand A, Martin H, Whitwell D, Taylor A, Gibbons CLMH. Five-year outcome of proximal femoral endoprosthetic arthroplasty for non-tumour indications. Bone Joint J. 2016;98:1463-1470.
Hartzler MA, Abdel MP, Sculco PK, Taunton MJ, Pagnano MW. Otto Aufranc Award: dual-mobility constructs in revision THA reduced dislocation, rerevision, and reoperation compared with large femoral heads. Clin Orthop Relat Res. 2018;476:293-301.
Henderson ER, Keeney BJ, Husson EG, et al. Nonmechanical revision indications portend certain limb-salvage failure following total femoral replacement. J Bone Joint Surg Am. 2020;102:1511-1520.
Henderson ER, Keeney BJ, Pala E, et al. The stability of the hip after the use of a proximal femoral endoprosthesis for oncological indications: analysis of variables relating to the patient and the surgical technique. Bone Joint J. 2017;99:531-537.
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
Korim MT, Esler CN, Ashford RU. Systematic review of proximal femoral arthroplasty for non-neoplastic conditions. J Arthroplasty. 2014;29:2117-2121.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J. Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. J Arthroplasty. 2018;33:3238-3245.
Leitner L, Posch F, Amerstorfer F, Sadoghi P, Leithner A, Glehr M. The dark side of arthroplasty: competing risk analysis of failed hip and knee arthroplasty with periprosthetic joint infection. J Arthroplasty. 2020;35:2601-2606.
Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60:217-220.
Lex JR, Evans S, Parry MC, Jeys L, Stevenson JD. Acetabular complications are the most common cause for revision surgery following proximal femoral endoprosthetic replacement: what is the best bearing option in the primary and revision setting? Bone Joint J. 2021;103:1633-1640.
McAlister IP, Perry KI, Mara KC, Hanssen AD, Berry DJ, Abdel MP. Two-stage revision of total hip arthroplasty for infection Is associated with a high rate of dislocation. J Bone Joint Surg Am. 2019;101:322-329.
Nho JH, Lee YK, Kim HJ, Ha YCH, Suh YS, Koo KH. Reliability and validity of measuring version of the acetabular component. J Bone Joint Surg Br. 2012;94:32-36.
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992-2994.
Petis SM, Abdel MP, Perry KI, Mabry TM, Hanssen AD, Berry DJ. Long-term results of a 2-stage exchange protocol for periprosthetic joint infection following total hip arthroplasty in 164 hips. J Bone Joint Surg Am. 2019;101:74-84.
Strony J, Sukhonthamarn K, Tan TL, Parvizi J, Brown SA, Nazarian DG. Worse outcomes are associated with proximal femoral replacement following periprosthetic joint infection. J Arthroplasty. 2022;37:559-564.
Theil C, Mollenbeck B, Gosheger G, et al. Acetabular erosion after bipolar hemiarthroplasty in proximal femoral replacement for malignant bone tumors. J Arthroplasty. 2019;34:2692-2697.
Unter Ecker N, Kocaoglu H, Zahar A, Haasper C, Gehrke T, Citak M. What is the dislocation and revision rate of dual-mobility cups used in complex revision THAs? Clin Orthop Relat Res. 2021;479:280-285.
Viste A, Perry KI, Taunton MJ, Hanssen AD, Abdel MP. Proximal femoral replacement in contemporary revision total hip arthroplasty for severe femoral bone loss: a review of outcomes. Bone Joint J. 2017;99:325-329.

Auteurs

Christoph Theil (C)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Jan Schwarze (J)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Maria Anna Smolle (MA)

Department of Orthopedics and Traumatology, Graz University Hospital, Graz, Austria.

Jan Pützler (J)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Burkhard Moellenbeck (B)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Kristian Nikolaus Schneider (KN)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Martin Schulze (M)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Sebastian Klingebiel (S)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Georg Gosheger (G)

Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Muenster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH